Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Tesla zahlt Cybertruck-Anzahlungen zurück: Letzter Ansturm vor Produktionsstopp (Investing.com DE) +++ TESLA Aktie +4,13%

AUTOLUS Aktie

 >AUTOLUS Aktienkurs 
1.11 EUR    -4.3%    (TradegateBSX)
Ask: 1.14 EUR / 8800 Stück
Bid: 1.12 EUR / 9000 Stück
Tagesumsatz: 9069 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
AUTOLUS Aktie über LYNX handeln
>AUTOLUS Performance
1 Woche: -15,0%
1 Monat: -26,6%
3 Monate: -32,6%
6 Monate: -20,0%
1 Jahr: -0,9%
laufendes Jahr: -27,0%
>AUTOLUS Aktie
Name:  AUTOLUS THERAP. SP.ADR/1
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US05280R1005 / A2JNZJ
Symbol/ Ticker:  6A3A (Frankfurt) / AUTL (NASDAQ)
Kürzel:  FRA:6A3A, ETR:6A3A, 6A3A:GR, NASDAQ:AUTL
Index:  -
Profil:  Autolus Therapeutics plc ADR is a clinical-stage biopharmaceutical company focused on developing programmed T-cell therapies for cancer and autoimmune diseases. The company applies modular cell-engineering technologies to design autologous T-cell tre..
>Volltext..
Marktkapitalisierung:  329.7 Mio. EUR
Unternehmenswert:  477.53 Mio. EUR
Umsatz:  105.26 Mio. EUR
EBITDA:  -211.4 Mio. EUR
Nettogewinn:  -250.88 Mio. EUR
Gewinn je Aktie:  -0.94 EUR
Schulden:  330.17 Mio. EUR
Liquide Mittel:  155.21 Mio. EUR
Operativer Cashflow:  -201.95 Mio. EUR
Bargeldquote:  2.95
Umsatzwachstum:  287.93%
Gewinnwachstum:  -21.93%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  AUTOLUS
Letzte Datenerhebung:  09.11.26
>AUTOLUS Kennzahlen
Aktien/ Unternehmen:
Aktien: 266.16 Mio. St.
Frei handelbar: 90.37%
Rückkaufquote: -
Mitarbeiter: 752
Umsatz/Mitarb.: 0.09 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 559.72%
Bewertung:
KGV: -
KGV lG: -
KUV: 3.22
KBV: 6.07
PEG-Ratio: -0.06
EV/EBITDA: -
Rentabilität:
Bruttomarge: 12.87%
Gewinnmarge: -238.34%
Operative Marge: -210.52%
Managementeffizenz:
Gesamtkaprendite: -46.04%
Eigenkaprendite: -132.68%
>AUTOLUS Peer Group
Gesundheit, Zell- & Gentherapie/ Gentechnik/ Erbkrankheiten, Autoimmunerkrankungen, Onkologie/ Krebs- Behandlung
 
09.11.26 - 15:33
Autolus Therapeutics Q3 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
09.11.26 - 13:18
Autolus Therapeutics to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire EN)
 
Autolus will present at the Jefferies Global Healthcare Conference on November 17, 2026 in London....
04.11.26 - 15:18
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2026 (GlobeNewswire EN)
 
Autolus announced the online publication of abstracts submitted to the American Society of Hematology (ASH) Annual Meeting....
03.11.26 - 22:48
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
 
Autolus awards inducement grant stock options....
26.10.26 - 21:18
Autolus Therapeutics to Report Third Quarter 2026 Financial Results and Host Conference Call on November 10, 2026 (GlobeNewswire EN)
 
Autolus will report Q3 2026 financial results on November 10, 2026....
05.10.26 - 19:45
All You Need to Know About Autolus Therapeutics (AUTL) Rating Upgrade to Buy (Zacks)
 
Autolus Therapeutics (AUTL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....
04.09.26 - 03:01
Insiderhandel: U.S. CCO & Country Gen Manager verkauft Aktien von Autolus Therapeutics im Wert von 15682 USD (Insiderkauf)
 
Piccina, Cintia - Vorstand - Tag der Transaktion: 2026-09-02...
18.08.26 - 17:48
Autolus (AUTL) Q2 2026 Earnings Call Transcript (Fool)
 
Revenue surged 119% year-over-year as gross margins turned positive for the first time....
11.08.26 - 13:06
Autolus Therapeutics GAAP EPS of -$0.15 beats by $0.04, revenue of $45.69M beats by $5.54M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.08.26 - 17:06
Autolus Therapeutics Q2 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.08.26 - 04:48
Top Biotech Gainers: UPC Cuts Loss, CPIX Gains Ahead Of Q2 Results, AUTL Builds Commercial Momentum (RTTNews)
 
Today's top biotech gainers include Universe Pharmaceuticals, which recently filed its SEC report for the six months ended March 31, 2026; Cumberland Pharma, ahead of its second-quarter 2026 financial results due Tuesday; and Autolus Therapeutics, following the release of its preliminary quarterly results, among others....
03.08.26 - 22:09
Autolus Therapeutics to Report Second Quarter 2026 Financial Results and Host Conference Call on August 11, 2026 (GlobeNewswire EN)
 
Autolus will report second quarter 2026 financial results on August 11, 2026....
03.08.26 - 16:12
CNH Industrial Posts Upbeat Q2 Earnings, Joins Autolus Therapeutics, Bowhead Specialty Holdings And Othe - Benzinga (Benzinga)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
03.08.26 - 13:15
Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors (GlobeNewswire EN)
 
Autolus announced preliminary second quarter 2026 AUCATZYL net product revenue that it has entered into a credit facility....
01.07.26 - 22:09
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
 
Autolus announced that the Compensation Committee of the Company's Board of Directors granted stock option awards....
25.06.26 - 13:03
Autolus Therapeutics to Participate in Upcoming Investor Conference (GlobeNewswire EN)
 
Autolus will present at the H.C. Wainwright Cell Therapy Conference on June 30, 2026....
12.06.26 - 10:03
Autolus Therapeutics Receives Prix Galien UK Award (GlobeNewswire EN)
 
Autolus Therapeutics was awarded Prix Galien UK 2026 Best Biotechnology Product...
10.06.26 - 17:30
Autolus Therapeutics (AUTL) Could Find a Support Soon, Here′s Why You Should Buy the Stock Now (Zacks)
 
After losing some value lately, a hammer chart pattern has been formed for Autolus Therapeutics (AUTL), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term....
01.06.26 - 17:30
Autolus Therapeutics PLC Sponsored ADR (AUTL) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
 
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?...
27.05.26 - 13:03
Autolus Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire EN)
 
Autolus will present and host meetings at two upcoming investor conferences....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Es gibt Tage, da geht alles schief. Umso schöner ist es, wenn man weiß, daß man bedingungslos geliebt wird. - James Morgan
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!